RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $16.